Find all the latest information
, arranged by types, translocations, and mutations.
Listed below are recently updated categories.
GvHD prophylaxis with PTCy allows for rapid hematopoietic reconstitution and improved survival in transplanted patients with severe aplastic anemia
A summary of the study conducted by DeZern and...
Steroid-refractory GvHD: long term outcomes and risk factors
Simona Pagliuca and colleagues conducted a retrospective study of acute GvHD and chronic GvHD following HSCT to determine the outcomes and...
Phase I follow-up results for CYP-001, a mesenchymal stem cell product for steroid-refractory acute GvHD
Positive results were announced today for the phase I trial (NCT02923375) of CYP-001, the first...
Donor macrophages promote human acute GvHD in allogeneic BMT
A study published by Laura Jardine and colleagues in the Journal of Clinical Investigation examined acute GvHD skin lesions, to identify...
ALPHA study: First-in-human data of ALLO-501 and ALLO-647 in R/R large B-cell or follicular lymphoma
During the American Society of Clinical Oncology (ASCO) Annual Meeting, the GvHD Hub was pleased to...
The use of PTCy as GvHD prophylaxis in patients treated with checkpoint inhibitors prior to allo-HCT improves outcomes
Juan Nieto and Betül Oran have each published studies on PTCy as GvHD prophylaxis...
Acute graft-versus-host disease
Late acute GvHD
Chronic graft-versus-host disease
Lower GI cGvHD
Upper GI cGvHD
Bone marrow GvHD